Albemarle Corporation (ALB) financials

Specialty Chemicals · NYSE · Materials

$91.00 -2.43% Close Oct 30, 2026 Live

Albemarle revenue and earnings by year

Albemarle's revenue was $5.14 billion in the fiscal year to December 31, 2025, down 4.4% from the year before. Net income was -$511 million, -9.9% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 7.5% a year on average.

RevenueNet income
$0$5.00B$10.0B
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue5.145.389.627.323.333.133.593.373.072.68
Revenue growth-4.4%-44.1%31.4%120.0%6.4%-12.8%6.4%9.9%14.7%—
Gross profit0.670.061.193.071.000.991.261.221.110.97
Gross margin13.0%1.2%12.3%42.0%30.0%31.8%35.0%36.1%36.0%36.2%
Operating income-0.37-1.780.252.470.800.510.670.700.570.48
Operating margin-7.1%-33.0%2.6%33.7%24.0%16.2%18.6%20.8%18.6%17.9%
Net income-0.51-1.181.572.690.120.380.530.690.050.64
Net margin-9.9%-21.9%16.4%36.7%3.7%12.0%14.9%20.6%1.8%24.0%
Diluted EPS-$5.76-$11.20$13.36$22.84$1.06$3.52$5.02$6.34$0.49$5.67
Free cash flow0.73-0.96-0.830.65-0.61-0.05-0.12-0.15-0.010.54

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ALB in Markets.

See also: ALB valuation and P/E history · ALB returns

No forecast, no recommendation. This page describes Albemarle Corporation from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.